130 related articles for article (PubMed ID: 26299454)
1. Eventual proapoptotic or anti-apoptotic impact of aberrantly expressed Cx43 and Cx26 can depend on ER-alpha overexpression in human endometrioid adenocarcinoma.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2015; 31(8):604-8. PubMed ID: 26299454
[TBL] [Abstract][Full Text] [Related]
2. STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different estrogen receptor-α immunoprofile.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Koda M; Sulkowska U; Famulski W; Sulkowski S
Gynecol Endocrinol; 2011 Aug; 27(8):536-40. PubMed ID: 21726118
[TBL] [Abstract][Full Text] [Related]
3. Comparison of E-cadherin with STAT3 and apoptosis regulators: Bak and Bcl-xL in endometrioid adenocarcinomas of different ER-alpha immunoprofile.
Sulkowska U; Wincewicz A; Kanczuga-Koda L; Koda M; Sulkowski S
Gynecol Endocrinol; 2018 Feb; 34(2):171-174. PubMed ID: 28937296
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of estrogen and progesterone receptor expression with connexins 26 and 43 in endometrial cancer.
Lesniewicz T; Kanczuga-Koda L; Baltaziak M; Jarzabek K; Rutkowski R; Koda M; Wincewicz A; Sulkowska M; Sulkowski S
Int J Gynecol Cancer; 2009 Oct; 19(7):1253-7. PubMed ID: 19820388
[TBL] [Abstract][Full Text] [Related]
5. Aberrant distributions and relationships among E-cadherin, beta-catenin, and connexin 26 and 43 in endometrioid adenocarcinomas.
Wincewicz A; Baltaziak M; Kanczuga-Koda L; Lesniewicz T; Rutkowski R; Sobaniec-Lotowska M; Sulkowski S; Koda M; Sulkowska M
Int J Gynecol Pathol; 2010 Jul; 29(4):358-65. PubMed ID: 20567150
[TBL] [Abstract][Full Text] [Related]
6. Association of STAT3 with Cx26 and Cx43 in human uterine endometrioid adenocarcinoma.
Sulkowska U; Febp AW; Sulkowski S
Oncol Lett; 2016 Jun; 11(6):4134-4138. PubMed ID: 27313754
[TBL] [Abstract][Full Text] [Related]
7. Suppressed gap junctional intercellular communication in carcinogenesis of endometrium.
Saito T; Nishimura M; Kudo R; Yamasaki H
Int J Cancer; 2001 Aug; 93(3):317-23. PubMed ID: 11433394
[TBL] [Abstract][Full Text] [Related]
8. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer.
Kanczuga-Koda L; Sulkowski S; Tomaszewski J; Koda M; Sulkowska M; Przystupa W; Golaszewska J; Baltaziak M
Oncol Rep; 2005 Aug; 14(2):325-9. PubMed ID: 16012710
[TBL] [Abstract][Full Text] [Related]
9. DNMT3A/3B overexpression might be correlated with poor patient survival, hypermethylation and low expression of ESR1/PGR in endometrioid carcinoma: an analysis of The Cancer Genome Atlas.
He D; Wang X; Zhang Y; Zhao J; Han R; Dong Y
Chin Med J (Engl); 2019 Jan; 132(2):161-170. PubMed ID: 30614867
[TBL] [Abstract][Full Text] [Related]
10. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
11. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
12. Connexin 26 correlates with Bcl-xL and Bax proteins expression in colorectal cancer.
Kanczuga-Koda L; Sulkowski S; Koda M; Skrzydlewska E; Sulkowska M
World J Gastroenterol; 2005 Mar; 11(10):1544-8. PubMed ID: 15770735
[TBL] [Abstract][Full Text] [Related]
13. Role of bcl-2 in endometrioid corpus cancer: an experimental study.
Mariani A; Sebo TJ; Cliby WA; Keeney GL; Riehle DL; Lesnick TG; Podratz KC
Anticancer Res; 2006; 26(2A):823-7. PubMed ID: 16619475
[TBL] [Abstract][Full Text] [Related]
14. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours.
Jamieson S; Going JJ; D'Arcy R; George WD
J Pathol; 1998 Jan; 184(1):37-43. PubMed ID: 9582525
[TBL] [Abstract][Full Text] [Related]
15. Different regulatory pathways of endometrial connexin expression: preimplantation hormonal-mediated pathway versus embryo implantation-initiated pathway.
Grümmer R; Hewitt SW; Traub O; Korach KS; Winterhager E
Biol Reprod; 2004 Jul; 71(1):273-81. PubMed ID: 15028626
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance and clinical importance of estrogen receptor alpha and beta in human endometrioid adenocarcinomas.
Mylonas I
Oncol Rep; 2010 Aug; 24(2):385-93. PubMed ID: 20596625
[TBL] [Abstract][Full Text] [Related]
17. Endometrial Endometrioid Carcinoma Metastases Show Decreased ER-Alpha and PR-A Expression Compared to Matched Primary Tumors.
Bartosch C; Monteiro-Reis S; Vieira R; Pereira A; Rodrigues M; Jerónimo C; Lopes JM
PLoS One; 2015; 10(8):e0134969. PubMed ID: 26252518
[TBL] [Abstract][Full Text] [Related]
18. Expression of connexin 26 in endometrial adenocarcinoma--analysis of correlations with some anatomoclinical features.
Lesniewicz T; Kanczuga-Koda L; Baltaziak M; Sulkowska M; Rutkowski R; Koda M; Sulkowski S
Folia Histochem Cytobiol; 2008; 46(2):171-6. PubMed ID: 18519234
[TBL] [Abstract][Full Text] [Related]
19. Expression of gap junctional connexins 26, 32 and 43 in bovine placentomes during pregnancy.
Pfarrer CD; Heeb C; Leiser R
Placenta; 2006 Jan; 27(1):79-86. PubMed ID: 16310041
[TBL] [Abstract][Full Text] [Related]
20. Development of a technique to detect the activated form of the progesterone receptor and correlation with clinical and histopathological characteristics of endometrioid adenocarcinoma of the uterine corpus.
Bonneterre J; Hutt E; Bosq J; Graham JD; Powell MA; Leblanc E; Fujiwara K; Herzog TJ; Coleman RL; Clarke CL; Gilles EM; Zukiwski AA; Monk BJ
Gynecol Oncol; 2015 Sep; 138(3):663-7. PubMed ID: 26142884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
